Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Flutamide emulgel with 1% Transcutol P absorbs better through the skin than other mixtures.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Using dutasteride during hair transplants improves results and reduces hair loss.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

BPH treatments can cause sexual side effects affecting quality of life.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Finasteride effectively slowed hair loss and promoted hair growth in Taiwanese men.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

Minoxidil can regrow hair, but cyproterone acetate doesn't help when used together.

Upadacitinib may effectively treat alopecia areata without side effects.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Finasteride can cause itching, burning, and other side effects that may not go away after treatment.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

These medications for BPH have known risks and may have new side effects.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

These medications for BPH have known risks and may have new side effects.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.